Plus: Jury selection begins in Hunter Biden’s criminal trial. Medical technology company Becton Dickinson agreed to acquire a unit of Edwards Lifesciences for $4.2 billion. J.R. Whalen reports.
Sign up for the WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices